Skip to main content
Log in

Aktuelle Strategien zur Vermeidung von ICD-Therapien

Current strategies to avoid ICD-therapies

  • Übersichten
  • Published:
Der Kardiologe Aims and scope

Zusammenfassung

Die Einführung des implantierbaren Kardioverter-Defibrillators (ICD) in die klinische Routine der Primär- und Sekundärprävention ventrikulärer Arrhythmien hat zu einer deutlichen Reduktion der Mortalität von Patienten mit hochgradig eingeschränkter linksventrikulärer Funktion geführt. Trotz des immensen Benefits dieser Therapie stellt im klinischen Alltag neben den adäquaten ICD-Therapien vor allem der hohe Anteil inadäquater Therapien ein großes Problem dar. Tachykard übergeleitetes Vorhofflimmern ist dabei neben supraventrikulären Tachykardien, Artefaktsensing und elektromagnetischen Interferenzen die häufigste Ursache für inadäquate ICD-Schocks. Da sowohl adäquate als auch inadäquate ICD-Schocks paradoxerweise die Mortalität erhöhen, kommt der Vermeidung von ICD-Therapien eine entscheidende Bedeutung zu. Neben den klassischen erweiterten Detektionskritieren (Stabilität, Onset und Morphologie des Kammerkomplexes) sowie den firmenspezifischen Zweikammer-ICD-Algorithmen gelingt eine Therapiereduktion vor allem durch Erhöhung der Detektionsfrequenz für ventrikuläre Tachykardien und Programmierung einer langen Detektionsdauer. Dies konnte eindrucksvoll in den neueren Studien wie MADIT-RIT, ADVANCE-III und PROVIDE gezeigt werden. Ein erhöhtes Risiko für Synkopen ist durch die Therapiereduktion nicht zur befürchten. Zusätzlich zur optimierten Programmierung kann der Anteil von adäquaten ICD-Therapien durch Antiarrhythmika und durch eine Katheterablation beeinflusst werden.

Abstract

Implantation of an internal cardioverter defibrillator (ICD) has become the routine therapy for primary and secondary prevention of ventricular arrhythmia due to its proven reduction of mortality. Despite the significant benefits for patients with highly reduced left ventricular function, ICD therapy, especially inappropriate ICD therapy, is a major concern in the daily routine. Causes of inappropriate ICD therapy can be divided into supraventricular arrhythmia, sensing problems and electromagnetic interference, with atrial fibrillation being the most common cause of inappropriate ICD shocks. As appropriate and inappropriate ICD therapies both seem to be associated with an increased mortality, physicians should focus on avoiding ICD therapy. Apart from enhanced detection criteria, such as stability, onset and QRS morphology as well as dual-chamber ICD algorithms, reduction of ICD therapy can safely be achieved by programming higher detection rates and prolonged detection as recent studies such as MADIT-RIT, ADVANCE III and PROVIDE were able to show. Antiarrhythmic drug therapy and catheter ablation of ventricular arrhythmia are further possibilities to reduce ICD therapy, especially in patients with repetitive ICD shocks due to recurrent ventricular arrhythmia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237

    Article  PubMed  CAS  Google Scholar 

  2. Connolly SJ, Dorian P, Roberts RS et al (2006) Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA 295:165–171

    Article  PubMed  CAS  Google Scholar 

  3. Connolly SJ, Hallstrom AP, Cappato R et al (2000) Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 21:2071–2078

    Article  PubMed  CAS  Google Scholar 

  4. Daubert JP, Zareba W, Cannom DS et al (2008) Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 51:1357–1365

    Article  PubMed  Google Scholar 

  5. Dorian P, Philippon F, Thibault B et al (2004) Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. Heart Rhythm 1:540–547

    Article  PubMed  Google Scholar 

  6. Fischer A, Ousdigian KT, Johnson JW et al (2012) The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients. Heart Rhythm 9:24–31

    Article  PubMed  Google Scholar 

  7. Friedman PA, Bradley D, Koestler C et al (2014) A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention. Europace 10.1093/europace/euu022 [Epub ahead of print]

  8. Friedman PA, Mcclelland RL, Bamlet WR et al (2006) Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation 113:2871–2879

    Article  PubMed  Google Scholar 

  9. Gasparini M, Proclemer A, Klersy C et al (2013) Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. JAMA 309:1903–1911

    Article  PubMed  CAS  Google Scholar 

  10. Goldenberg I, Gillespie J, Moss AJ et al (2010) Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 122:1265–1271

    Article  PubMed  Google Scholar 

  11. Israel CW (2008) How to avoid inappropriate therapy. Curr Opin Cardiol 23:65–71

    Article  PubMed  Google Scholar 

  12. Klein RC, Raitt MH, Wilkoff BL et al (2003) Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol 14:940–948

    Article  PubMed  Google Scholar 

  13. Kuck KH, Ernst S, Dorwarth U et al (2007) Guidelines for catheter ablation. Clin Res Cardiol 96:833–849

    Article  PubMed  Google Scholar 

  14. Kuck KH, Schaumann A, Eckardt L et al (2010) Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 375:31–40

    Article  PubMed  Google Scholar 

  15. Moss AJ, Schuger C, Beck CA et al (2012) Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 367:2275–2283

    Article  PubMed  CAS  Google Scholar 

  16. Poole JE, Johnson GW, Hellkamp AS et al (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359:1009–1017

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  17. Powell BD, Saxon LA, Boehmer JP et al (2013) Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. J Am Coll Cardiol 62:1674–1679

    Article  PubMed  Google Scholar 

  18. Reddy VY, Reynolds MR, Neuzil P et al (2007) Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 357:2657–2665

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  19. Ruwald AC, Sood N, Ruwald MH et al (2013) Frequency of inappropriate therapy in patients implanted with dual- versus single-chamber ICD devices in the ICD arm of MADIT-CRT. J Cardiovasc Electrophysiol 24:672–679

    Article  PubMed  Google Scholar 

  20. Saeed M, Hanna I, Robotis D et al (2014) Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE study. J Cardiovasc Electrophysiol 25:52–59

    Article  PubMed  Google Scholar 

  21. Saxon LA, Hayes DL, Gilliam FR et al (2010) Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study. Circulation 122:2359–2367

    Article  PubMed  Google Scholar 

  22. Sweeney MO, Sherfesee L, Degroot PJ et al (2010) Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 7:353–360

    Article  PubMed  Google Scholar 

  23. Sweeney MO, Wathen MS, Volosin K et al (2005) Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation 111:2898–2905

    Article  PubMed  CAS  Google Scholar 

  24. Tan VH, Wilton SB, Kuriachan V et al (2014) Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol 7:164–170

    Article  PubMed  Google Scholar 

  25. Theuns DA, Rivero-Ayerza M, Boersma E et al (2008) Prevention of inappropriate therapy in implantable defibrillators: a meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms. Int J Cardiol 125:352–357

    Article  PubMed  Google Scholar 

  26. Van Rees JB, Borleffs CJ, De Bie MK et al (2011) Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol 57:556–562

    Article  Google Scholar 

  27. Koglek W, Brandl J (2013) ICD-Detektionsalgorithmen. In: Fröhlig G et al (Hrsg) Herzschrittmacher- und Defibrillatortherapie. Thieme, Stuttgart, S 477–485

  28. Wathen MS, Degroot PJ, Sweeney MO et al (2004) Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 110:2591–2596

    Article  PubMed  Google Scholar 

  29. Wilkoff BL, Ousdigian KT, Sterns LD et al (2006) A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol 48:330–339

    Article  PubMed  Google Scholar 

  30. Wilkoff BL, Williamson BD, Stern RS et al (2008) Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 52:541–550

    Article  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. J. Vogler, N. Gosau, J. Moser und B.A. Hoffmann: kein Interessenkonflikt. S. Willems: Referententätigkeiten: Biosense Webster, Boston Scientific, St. Jude Medical, Sanofi-Aventis, Bristol-Myers Squibb; Beratertätigkeit: Boehringer Ingelheim, Bayer. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Vogler.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vogler, J., Gosau, N., Moser, J. et al. Aktuelle Strategien zur Vermeidung von ICD-Therapien. Kardiologe 8, 393–398 (2014). https://doi.org/10.1007/s12181-014-0605-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-014-0605-9

Schlüsselwörter

Keywords

Navigation